Pam Belluck is a writer covering science and medicine for the New York Times.
Segment
Listen
Promising new treatments for pancreatic cancer and ALS
A new pancreatic cancer drug doubles survival times. And a new treatment for a rare form of ALS slows and improves some patients’ symptoms.
Segment
Listen
12:14
FDA’s Approval Of Debated Alzheimer’s Treatment Raises Controversy
The FDA approved the first drug for treatment of Alzheimer’s disease in almost 20 years. But the benefits of the costly medication aren’t clear.